[1]
Molica, M. 2024. SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY: Long-lasting disease remission with third line therapy with gilteritinib. Mediterranean Journal of Hematology and Infectious Diseases. 16, 1 (Oct. 2024), e2024079. DOI:https://doi.org/10.4084/MJHID.2024.079.